The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents-Reference-Cited by-同舟云学术

The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents

Published:2022-10-12 Issue:11 Volume:5 Page:1097-1108
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Keuler Tim¹,Lemke Carina¹,Elsinghorst Paul W.¹²^ORCID,Iriepa Isabel³,Chioua Mourad⁴,Martínez-Grau María Angeles⁵,Beadle Christopher D.⁶,Vetman Tatiana⁷,López-Muñoz Francisco⁸,Wille Timo⁹,Bartz Ulrike¹⁰,Deuther-Conrad Winnie¹¹,Marco-Contelles José⁴,Gütschow Michael¹^ORCID

Affiliation:

1. Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany

2. Central Institute of the Bundeswehr Medical Service Munich, Ingolstädter Landstraße 102, 85748 Garching Germany

3. Universidad de Alcalá, Departamento de Química Orgánica y Química Inorgánica, Ctra. Madrid-Barcelona, 28871 Alcalá de Henares, Madrid España

4. Laboratory of Medicinal Chemistry, IQOG, CSIC, C/Juan de la Cierva 3, 28006 Madrid, Spain

5. Lilly Research Laboratories, Eli Lilly & Company, Avda. de la Industria 30, 28108 Alcobendas, Madrid Spain

6. Lilly Research Centre, Eli Lilly & Company, Erl Wood Manor, Windlesham, Surrey GU20 6PH, United Kingdom

7. Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285, United States

8. Faculty of Health, Camilo José Cela University of Madrid (UCJC), Neuropsychopharmacology Unit, “Hospital 12 de Octubre” Research Institute, 28692 Madrid, Spain

9. Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstraße 11, 80937 München, Germany

10. Department of Natural Sciences, University of Applied Sciences Bonn-Rhein-Sieg, von-Liebig-Straße 20, 53359 Rheinbach, Germany

11. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Neuroradiopharmaceuticals, 04318 Leipzig, Germany

Funder

J?rgen Manchot Stiftung

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.2c00097

Reference59 articles.

1. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease

2. Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach

3. Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds

4. Cholinesterase inhibitors as Alzheimer's therapeutics (Review)

5. Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromenone: An emerging scaffold in anti-Alzheimer drug discovery;Bioorganic & Medicinal Chemistry Letters;2024-10

2. Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease;Expert Opinion on Drug Discovery;2023-10-06

3. Sphingoid Bases Regulate the Sigma-1 Receptor—Sphingosine and N,N’-Dimethylsphingosine Are Endogenous Agonists;International Journal of Molecular Sciences;2023-02-04